James Meek, MPH
Associate Director, Yale Emerging Infections Program, and Lecturer in Epidemiology (Microbial Diseases)DownloadHi-Res Photo
Cards
Additional Titles
Associate Director, Yale Emerging Infections Program
Contact Info
About
Titles
Associate Director, Yale Emerging Infections Program, and Lecturer in Epidemiology (Microbial Diseases)
Associate Director, Yale Emerging Infections Program
Biography
Mr. Meek is the associate director of the Yale office of the Connecticut Emerging Infections Program, a joint effort between the State of Connecticut Department of Public Health, the Yale School of Public Health Department of Epidemiology and Public Health (EPH), and the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. This CDC-funded program is one of twelve programs nationwide that seek to assess, through population-based surveillance, the public health impact of emerging infectious diseases and to evaluate methods for their prevention and control in the community.
In the EIP, Mr. Meek has overseen the establishment and maintenance of regional and statewide population-based surveillance systems for multiple emerging infections (foodborne disease, tickborne disease, liver disease, HPV disease, fungal disease, respiratory disease) and, based on surveillance findings, implemented research studies (case-control, cohort, vaccine effectiveness) to identify risk factors and evaluate prevention programs. The Yale office of the Connecticut EIP has provided training in surveillance and applied public health to over 300 MPH/doctoral students through internships, practicum experiences and thesis projects.
Appointments
Epidemiology of Microbial Diseases
LecturerSecondary
Other Departments & Organizations
- Connecticut Emerging Infections Program
- Epidemiology of Microbial Diseases
- Epidemiology of Microbial Diseases (EMD)
- HPV Working Group (Niccolai Lab)
- Yale School of Public Health
- Yale School of Public Health - NEW
Education & Training
- MPH
- University of Connecticut (2000)
Research
Overview
Medical Research Interests
Epidemiology; Tick Control; Ticks; Zoonoses
Public Health Interests
Respiratory Disease/Infections; Emerging Infectious Diseases; Enteric Diseases; Antimicrobial Resistance
- View Lab Website
CT Emerging Infections Program
Research at a Glance
Yale Co-Authors
Frequent collaborators of James Meek's published research.
Publications Timeline
A big-picture view of James Meek's research output by year.
Research Interests
Research topics James Meek is interested in exploring.
Kimberly Yousey-Hindes, MPH
AmberJean P. Hansen, MPH, CCRP
Monica Brackney, MS
David Banach, MD, MPH, MS
Erol Fikrig, MD
Forrest W. Crawford, PhD
106Publications
6,463Citations
Publications
2024
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach
Devine O, Pham H, Gunnels B, Reese H, Steele M, Couture A, Iuliano D, Sachdev D, Alden N, Meek J, Witt L, Ryan P, Reeg L, Lynfield R, Ropp S, Barney G, Tesini B, Shiltz E, Sutton M, Talbot H, Reyes I, Havers F. Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach. Influenza And Other Respiratory Viruses 2024, 18: e70026. PMID: 39440677, PMCID: PMC11497105, DOI: 10.1111/irv.70026.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsBarriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017.
Hansen A, Wilkinson M, Niesobecki S, Rutz H, Meek J, Niccolai L, Hinckley A, Hook S. Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017. Journal Of Public Health Management And Practice 2024, 31: e52-e60. PMID: 39321400, DOI: 10.1097/phh.0000000000002033.Peer-Reviewed Original ResearchConceptsPersonal safety concernsPreventive measuresBarriers to consistent usePublic health programsLogistic regression modelsHealth programsTickborne diseasesDisease prevention measuresDemographic variablesPrimary barrierOutdoor activitiesTick checksDescriptive analysisOnline surveyRegression modelsSafety concernsCost concernsNatural pesticidesIncreased uptakePreventionBarriersTick habitatsSurveyConnecticutConcernsCharacteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, Johnston H, Basiliere E, Meek J, Olson D, Fridkin S, Wilson L, Perlmutter R, Holzbauer S, D’Heilly P, Phipps E, Flores K, Dumyati G, Pierce R, Ocampo V, Wilson C, Watkins J, Gerding D, McDonald L. Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences. Open Forum Infectious Diseases 2024, 11: ofae127. PMID: 38577028, PMCID: PMC10993058, DOI: 10.1093/ofid/ofae127.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRecurrent Clostridioides difficile infectionClostridioides difficile infectionInitial CDINitrofurantoin useMultiple recurrent Clostridioides difficile infectionsPositive testPositive C. difficile testMultiple CDI recurrencesMultivariate logistic regression analysisPrevent further recurrenceAssociated with increased riskIntervention study designProportion of patientsTime of presentationCharacteristics of patientsLogistic regression analysisClinical decision makingCDI recurrenceChronic hemodialysisAdjunctive therapyIncreased riskMultivariate analysisStudy designPatientsClinical setting
2023
473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 — COVID-NET, 14 U.S. States, January 2021–January 2023
Havers F, Whitaker M, Milucky J, Patton M, Chatwani B, Chai S, Armistead I, Meek J, Openo K, Weigel A, Ryan P, Nunez V, Bye E, Rudin D, Engesser K, Bushey S, Moran N, Sutton M, Talbot H, Olsen K, Taylor C. 473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 — COVID-NET, 14 U.S. States, January 2021–January 2023. Open Forum Infectious Diseases 2023, 10: ofad500.543. PMCID: PMC10679218, DOI: 10.1093/ofid/ofad500.543.Peer-Reviewed Original ResearchAltmetricConceptsSARS-CoV-2 testPositive SARS-CoV-2 testCOVID-19-Associated Hospitalization Surveillance NetworkHospitalized pregnant patientsPregnant patientsRespiratory symptomsClinical outcomesBooster dosesCOVID-19 respiratory symptomsIntensive care unit admissionPositive SARS-CoV-2SARS-CoV-2 infectionPrimary vaccination seriesSymptomatic pregnant patientsCare unit admissionAdverse clinical outcomesSevere clinical outcomesCOVID-19 vaccinationCOVID-19 infectionSARS-CoV-2Unit admissionVaccination seriesAsymptomatic patientsChart abstractionMechanical ventilation1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021.
Patel K, Kirley P, Kawasaki B, Meek J, Openo K, Monroe M, Henderson J, Lynfield R, Sosin D, Rowe A, Bushey S, Shiltz E, Sutton M, Talbot H, Swain A, Whitaker M, Taylor C, Havers F. 1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021. Open Forum Infectious Diseases 2023, 10: ofad500.1205. PMCID: PMC10677354, DOI: 10.1093/ofid/ofad500.1205.Peer-Reviewed Original ResearchConceptsCOVID-19-Associated Hospitalization Surveillance NetworkPost-discharge mortalityCOVID-19-associated hospitalizationLaboratory-confirmed COVID-19Hospitalization ratesHospital mortalityChart reviewAdult ageLaboratory-confirmed COVID-19-associated hospitalizationsCOVID-19Positive SARS-CoV-2 testAge groupsPopulation-based surveillance systemSARS-CoV-2 testSurveillance networkDetailed chart reviewFull chart reviewDeath certificate dataProportion of mortalityHospital dischargeCase definitionCertificate dataHospitalizationHospitalMortality684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, Johnston H, Basiliere E, Meek J, Olson D, Fridkin S, Wilson L, Perlmutter R, Holzbauer S, D’Heilly P, Phipps E, Flores K, Dumyati G, Pierce R, Ocampo V, Wilson C, Watkins J, Gerding D, McDonald L. 684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences. Open Forum Infectious Diseases 2023, 10: ofad500.746. PMCID: PMC10677783, DOI: 10.1093/ofid/ofad500.746.Peer-Reviewed Original ResearchConceptsEmerging Infections ProgramClostridioides difficile infectionInitial Clostridioides difficile infectionInitial CDICharacteristics of patientsRecurrent CDIPositive testNitrofurantoin useRecent hospitalizationDifficile infectionPrevention's Emerging Infections ProgramRecurrent Clostridioides difficile infectionMultivariable logistic regression modelMultiple recurrent CDIPrevious positive testTime of presentationFull chart reviewGrant/research supportPrior positive testLogistic regression modelsRace/ethnicityChronic hemodialysisAdjunctive therapyChart reviewConclusions PatientsOperational Considerations for Using Deer-Targeted 4-Poster Tick Control Devices in a Tick-borne Disease Endemic Community
Hornbostel V, Meek J, Hansen A, Niesobecki S, Nawrocki C, Hinckley A, Connally N. Operational Considerations for Using Deer-Targeted 4-Poster Tick Control Devices in a Tick-borne Disease Endemic Community. Journal Of Public Health Management And Practice 2023, 30: 111-121. PMID: 37566802, PMCID: PMC10840788, DOI: 10.1097/phh.0000000000001809.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsEndemic areasFuture public health interventionsPublic health interventionsDisease-endemic areasPublic health agenciesEndemic communitiesHealth interventionsCommunity settingsCommunity-wide approachEffectiveness studiesMonthly costHealth agenciesTick-borne diseasesLone star tickPersonal protectionAcceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA
Nawrocki C, Piedmonte N, Niesobecki S, Rowe A, Hansen A, Kaufman A, Foster E, Meek J, Niccolai L, White J, Backenson B, Eisen L, Hook S, Connally N, Hornbostel V, Hinckley A. Acceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA. Ticks And Tick-borne Diseases 2023, 14: 102231. PMID: 37531890, PMCID: PMC10883357, DOI: 10.1016/j.ttbdis.2023.102231.Peer-Reviewed Original ResearchCitationsAltmetricEstimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
Dalton A, Diallo A, Chard A, Moulia D, Deputy N, Fothergill A, Kracalik I, Wegner C, Markus T, Pathela P, Still W, Hawkins S, Mangla A, Ravi N, Licherdell E, Britton A, Lynfield R, Sutton M, Hansen A, Betancourt G, Rowlands J, Chai S, Fisher R, Danza P, Farley M, Zipprich J, Prahl G, Wendel K, Niccolai L, Castilho J, Payne D, Cohn A, Feldstein L, Group C, Group C, Saadeh K, Snyder R, Anderson M, Anguiano V, Nadle J, Rothrock G, Jones S, Duval L, Herlihy R, Stringer G, Weber R, Phan Q, Sosa L, Meek J, Lee M, Morrow A, Willut C, Carlson J, Kamis K, Nishiyama M, Simien G, Colasanti J, van der Woude T, Archer R, Finn L, Lam J, Moulton B, Peterson E, Bolan R, Garcia-Lopez G, Como-Sabetti K, Ruff A, Schneider D, Robinson T, Anderson B, Engesser K, McGuire S, Rowe A, Pride C, Mitchell J, Tourkina Y, Cieslak P, Fill M, Wiedeman C, Dumyati G, Felsen C, Lewnard J, Akoko B, Mansilla-Dubon K, Ndi D, Talbot H, Tiwari S, Wyatt D. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 553-558. PMID: 37200229, PMCID: PMC10205167, DOI: 10.15585/mmwr.mm7220a3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAdjusted vaccine effectivenessVaccine effectivenessCase-control studyFull vaccinationEmerging Infections Program sitesEmergency use authorizationDuration of protectionPrevention of smallpoxImmunocompetent participantsImmunocompromised participantsControl patientsImmunization PracticesPartial vaccinationIntradermal injectionSubcutaneous injectionVaccinationMonkeypox casesAdministration routeDrug AdministrationVaccine accessLaboratory capacityTransgender adultsVaccineTransgender personsAdvisory CommitteeBacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022
Shah M, Patel K, Milucky J, Taylor C, Reingold A, Armistead I, Meek J, Anderson E, Weigel A, Reeg L, Como‐Sabetti K, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot H, Chatelain R, Havers F, Team T. Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022. Influenza And Other Respiratory Viruses 2023, 17: e13107. PMID: 36875205, PMCID: PMC9981874, DOI: 10.1111/irv.13107.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsDay of admissionSARS-CoV-2 infectionHospitalized adultsViral infectionBacterial coinfectionCOVID-19Laboratory-confirmed SARS-CoV-2 infectionBacterial infectionsPopulation-based surveillance systemRhinovirus/enterovirusRespiratory syncytial virusBacterial pathogensCoV-2 virusClinical featuresClinical outcomesViral coinfectionSyncytial virusHuman metapneumovirusParainfluenza virusRisk factorsSterile sitesEndemic coronavirusesRelative riskRelevant bacterial pathogensGram-negative rods
News
News
- May 18, 2020Source: STAT News
Life as a Covid-19 contact tracer: sleuthing, stress, and veering off-script
- March 11, 2020Source: CT Mirror
With coronavirus spreading in Connecticut, when is it appropriate to close schools?
- December 25, 2017
Grant renewed for infectious disease surveillance
- July 19, 2017Source: News 8 wtnh.com
Yale study shows pet owners at higher risk for tick exposure
Get In Touch
Contacts
Locations
Yale Emerging Infections Program
Academic Office
1 Church Street, Ste 7th Floor
New Haven, CT 06510
Fax
203.764.4357Appointments
203.737.6339